International Patent: A TREATMENT FOR PATIENTS WITH MOOD DISORDERS USING N-ETHYL-2-(5- FLUORO-17/-INDOL-3-YL)-A-METHYLETHAN-L-AMINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF

GENEVA, Aug. 31 -- GILGAMESH PHARMACEUTICALS, INC. filed a patent application (US2026/015845) for “A TREATMENT FOR PATIENTS WITH MOOD DISORDERS USING N-ETHYL-2-(5- FLUORO-17/-INDOL-3-YL)-A-METHYLETHAN-L-AMINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF”. With publication no. WO/2026/178240, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/055

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....